Patients with hepatitis C treated with combination therapy of pegylated interferon and ribavirin had better outcomes when taking a weight-based dosage of ribavirin compared to a flat dosage. This ...

New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual scientific meeting, found that the recommended weight-based or non-weight-based dose of ...

Please provide your email address to receive an email when new articles are posted on . Patients with cancer and overweight or obesity had better outcomes with immune checkpoint inhibitors than ...

The UK’s medicines regulator has approved a stronger dose of the weight loss jab Wegovy as demand for the drug is set to soar. The new 7.2mg dose is three times higher than the current approved dosage ...

Immune checkpoint inhibitors, a class of drugs used in approximately forty unique cancer indications, are a sizable component of the economic burden of cancer care in the US. Instead of personalized ...

A patient who developed atrial fibrillation resulting from the failure to adjust their levothyroxine dose after rapid, significant weight loss while on the antiobesity drug tirzepatide (Zepbound) ...